Summit Therapeutics Inc (SMMT)
19.00
+0.58
(+3.15%)
USD |
NASDAQ |
Nov 22, 16:00
19.02
+0.02
(+0.11%)
After-Hours: 20:00
Summit Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | -9.72K% |
| June 30, 2022 | -7.14K% |
| March 31, 2022 | -8.56K% |
| December 31, 2021 | -10.80K% |
| September 30, 2021 | -1.50K% |
| June 30, 2021 | -42.84K% |
| March 31, 2021 | -9.11K% |
| December 31, 2020 | -7.32K% |
| September 30, 2020 | -9.80K% |
| June 30, 2020 | -8.99K% |
| March 31, 2020 | -1.89K% |
| October 31, 2019 | -5.67K% |
| Date | Value |
|---|---|
| July 31, 2019 | -4.09K% |
| April 30, 2019 | -1.62K% |
| January 31, 2019 | -169.8% |
| October 31, 2018 | -1.21K% |
| July 31, 2018 | 70.17% |
| April 30, 2018 | -150.8% |
| January 31, 2018 | -307.2% |
| October 31, 2017 | -32.84% |
| July 31, 2017 | -69.07% |
| April 30, 2017 | -275.5% |
| January 31, 2017 | -304.6% |
| October 31, 2016 | -795.5% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-42.84K%
Minimum
Jun 2021
-1.50K%
Maximum
Sep 2021
-10.70K%
Average
-8.99K%
Median
Jun 2020
Profit Margin (Quarterly) Benchmarks
| Merck & Co Inc | 18.95% |
| Terns Pharmaceuticals Inc | -- |
| Instil Bio Inc | -- |
| Viking Therapeutics Inc | -- |
| Moderna Inc | 0.70% |